Rankings
▼
Calendar
NUVL FY 2024 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena
NUVL
Nuvalent, Inc.
$8B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$280M
Net Income
-$261M
EPS (Diluted)
$-3.93
Cash Flow
Operating Cash Flow
-$185M
Free Cash Flow
-$185M
Stock-Based Comp.
$61M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$72M
Stockholders' Equity
$1.1B
Cash & Equivalents
$146M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$280M
-$149M
-87.5%
Net Income
-$261M
-$126M
-106.6%
← Q4 2023
All Quarters
Q1 2024 →